|
|
| | Geldanamycin, 17-demethoxy-17-[[3-(dimethylamino)propyl]amino]- Basic information |
| | Geldanamycin, 17-demethoxy-17-[[3-(dimethylamino)propyl]amino]- Chemical Properties |
| Boiling point | 819.7±65.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | pka | 8.57±0.70(Predicted) |
| | Geldanamycin, 17-demethoxy-17-[[3-(dimethylamino)propyl]amino]- Usage And Synthesis |
| Uses | 17-DMAP-GA, a Geldanamycin (HY-15230) analogue, is an inhibitor of HSP90. 17-DMAP-GA causes cell cycle abnormalities[1][2]. | | References | [1] Jurczyszyn A, et al. Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor. J Cancer. 2014;5(6):480-490. Published 2014 May 31. DOI:10.7150/jca.8731 [2] Tian ZQ, et al. Synthesis and biological activities of novel 17-aminogeldanamycin derivatives. Bioorg Med Chem. 2004;12(20):5317-5329. DOI:10.1016/j.bmc.2004.07.053 |
| | Geldanamycin, 17-demethoxy-17-[[3-(dimethylamino)propyl]amino]- Preparation Products And Raw materials |
|